The recent controversy surrounding a paediatrician in Hyderabad, who challenged the marketing of specific electrolyte drinks labeled as ‘oral rehydration solution’ (ORS), raises significant concerns beyond the product itself. Central to this issue is a pressing question: who within the medical community will advocate when practices are clearly misaligned with established standards?
The paediatrician’s actions led to judicial involvement, prompting the Food Safety and Standards Authority of India (FSSAI) to issue a directive banning the mislabeling of the product. However, this incident underscores how easily scientific standards can be obscured in commercial settings.
Reactions from the medical community have been mixed. Some clinicians expressed support for the paediatrician, while the Indian Academy of Pediatrics (IAP) published a detailed standard operating procedure outlining the appropriate composition and use of ORS. Nevertheless, the IAP refrained from confronting the involved manufacturers directly and has not formally supported the paediatrician, who has since resigned from the IAP following legal threats from some manufacturers.
Institutional caution is often regarded as pragmatic, yet persistent silence can easily be viewed as complicity. Professional organizations are tasked not only with guiding practice but also with maintaining standards, particularly when such standards are challenged.
Some members of the medical community have raised doubts about the paediatrician’s motives, suggesting her actions were motivated by a desire for attention or personal benefit. Such insinuations distract from the fundamental issue. It is easier to challenge intent than to engage with the concerns presented.
The broader issue is recognizable. Many professionals remain focused on clinical duties and show understandable disengagement from institutional issues. Others pursuing leadership positions often find themselves within networks that prioritize consensus over confrontation, leading the system to reward compliance rather than dissent.
Historically, progress in medicine has rarely stemmed from unchallenged agreement; it has instead relied on individuals willing to question prevailing practices, frequently at personal and professional risks. Speaking out in such contexts is seldom comfortable and often carries consequences.
The current issue transcends the fate of a single product or corporation. ORS is one of the most effective and widely recognized public health interventions, relying on its simplicity and precise formulation. Any dilution or misrepresentation of ORS through marketing or labeling compromises decades of efforts to reduce child mortality.
Therefore, individuals who raise such critical concerns are vital to the system, providing necessary checks when institutions hesitate and reminding the community that medical standards are not negotiable.
Professional organizations will evolve, and leadership will shift. However, the readiness to question, challenge, and uphold what is right—even when inconvenient—remains a crucial measure of professional integrity. When advocating for the right course of action becomes the exception, the implications extend far beyond any single incident.
(The writer is a past national convener of the IAP Committee on Immunization.)
Published on May 4, 2026.
